Cargando…
Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164887/ https://www.ncbi.nlm.nih.gov/pubmed/34053460 http://dx.doi.org/10.1186/s13063-021-05329-y |
_version_ | 1783701211896086528 |
---|---|
author | Gagneux-Brunon, Amandine Schilte, Clémentine Garcin, Arnauld Jolly, Nathalie Vray, Muriel Schaeffer, Laura Duval, Xavier Hoen, Bruno Botelho-Nevers, Elisabeth |
author_facet | Gagneux-Brunon, Amandine Schilte, Clémentine Garcin, Arnauld Jolly, Nathalie Vray, Muriel Schaeffer, Laura Duval, Xavier Hoen, Bruno Botelho-Nevers, Elisabeth |
author_sort | Gagneux-Brunon, Amandine |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8164887 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81648872021-06-01 Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic Gagneux-Brunon, Amandine Schilte, Clémentine Garcin, Arnauld Jolly, Nathalie Vray, Muriel Schaeffer, Laura Duval, Xavier Hoen, Bruno Botelho-Nevers, Elisabeth Trials Letter BioMed Central 2021-05-30 /pmc/articles/PMC8164887/ /pubmed/34053460 http://dx.doi.org/10.1186/s13063-021-05329-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter Gagneux-Brunon, Amandine Schilte, Clémentine Garcin, Arnauld Jolly, Nathalie Vray, Muriel Schaeffer, Laura Duval, Xavier Hoen, Bruno Botelho-Nevers, Elisabeth Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic |
title | Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic |
title_full | Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic |
title_fullStr | Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic |
title_full_unstemmed | Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic |
title_short | Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic |
title_sort | acceptability of a covid-19 pre-exposure prophylaxis trial with hydroxychloroquine in french healthcare workers during the first wave of covid-19 pandemic |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164887/ https://www.ncbi.nlm.nih.gov/pubmed/34053460 http://dx.doi.org/10.1186/s13063-021-05329-y |
work_keys_str_mv | AT gagneuxbrunonamandine acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT schilteclementine acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT garcinarnauld acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT jollynathalie acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT vraymuriel acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT schaefferlaura acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT duvalxavier acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT hoenbruno acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic AT botelhoneverselisabeth acceptabilityofacovid19preexposureprophylaxistrialwithhydroxychloroquineinfrenchhealthcareworkersduringthefirstwaveofcovid19pandemic |